Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aetna Inc. stock logo
AET
Aetna
$212.70
$212.70
$166.88
$213.36
$69.64B0.713.69 million shs11.86 million shs
CVS Health Corporation stock logo
CVS
CVS Health
$78.42
+0.7%
$72.28
$43.56
$79.68
$99.46B0.69.32 million shs4.14 million shs
Guardant Health, Inc. stock logo
GH
Guardant Health
$62.31
-3.0%
$59.43
$20.14
$68.00
$7.77B1.532.38 million shs1.33 million shs
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
$35.57
-1.2%
$36.18
$24.05
$38.00
$20.72B0.64.39 million shs849,897 shs
Tempus AI, Inc. stock logo
TEM
Tempus AI
$95.08
-1.4%
$78.89
$31.36
$104.32
$16.59B4.8711.92 million shs5.86 million shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aetna Inc. stock logo
AET
Aetna
0.00%0.00%0.00%0.00%0.00%
CVS Health Corporation stock logo
CVS
CVS Health
0.00%+0.49%+3.85%+21.02%+16.90%
Guardant Health, Inc. stock logo
GH
Guardant Health
0.00%+2.20%+16.98%+29.03%+200.09%
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
0.00%-0.17%-0.96%-0.63%+28.52%
Tempus AI, Inc. stock logo
TEM
Tempus AI
0.00%+5.16%+11.59%+66.71%+97.44%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aetna Inc. stock logo
AET
Aetna
$212.70
$212.70
$166.88
$213.36
$69.64B0.713.69 million shs11.86 million shs
CVS Health Corporation stock logo
CVS
CVS Health
$78.42
+0.7%
$72.28
$43.56
$79.68
$99.46B0.69.32 million shs4.14 million shs
Guardant Health, Inc. stock logo
GH
Guardant Health
$62.31
-3.0%
$59.43
$20.14
$68.00
$7.77B1.532.38 million shs1.33 million shs
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
$35.57
-1.2%
$36.18
$24.05
$38.00
$20.72B0.64.39 million shs849,897 shs
Tempus AI, Inc. stock logo
TEM
Tempus AI
$95.08
-1.4%
$78.89
$31.36
$104.32
$16.59B4.8711.92 million shs5.86 million shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aetna Inc. stock logo
AET
Aetna
0.00%0.00%0.00%0.00%0.00%
CVS Health Corporation stock logo
CVS
CVS Health
0.00%+0.49%+3.85%+21.02%+16.90%
Guardant Health, Inc. stock logo
GH
Guardant Health
0.00%+2.20%+16.98%+29.03%+200.09%
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
0.00%-0.17%-0.96%-0.63%+28.52%
Tempus AI, Inc. stock logo
TEM
Tempus AI
0.00%+5.16%+11.59%+66.71%+97.44%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aetna Inc. stock logo
AET
Aetna
0.00
N/AN/AN/A
CVS Health Corporation stock logo
CVS
CVS Health
2.92
Moderate Buy$79.801.76% Upside
Guardant Health, Inc. stock logo
GH
Guardant Health
2.92
Moderate Buy$65.865.69% Upside
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
3.20
Buy$46.0029.32% Upside
Tempus AI, Inc. stock logo
TEM
Tempus AI
2.43
Hold$71.83-24.45% Downside

Current Analyst Ratings Breakdown

Latest AET, CVS, RPRX, TEM, and GH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/10/2025
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$55.00 ➝ $54.00
10/9/2025
CVS Health Corporation stock logo
CVS
CVS Health
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$76.00 ➝ $88.00
10/8/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
10/8/2025
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C+)Buy (B-)
10/8/2025
Tempus AI, Inc. stock logo
TEM
Tempus AI
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
10/7/2025
CVS Health Corporation stock logo
CVS
CVS Health
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$84.00 ➝ $103.00
10/7/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$60.00 ➝ $68.00
10/2/2025
Guardant Health, Inc. stock logo
GH
Guardant Health
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$60.00 ➝ $70.00
9/30/2025
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$42.00
9/30/2025
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$42.00
9/27/2025
CVS Health Corporation stock logo
CVS
CVS Health
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C-)
(Data available from 10/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aetna Inc. stock logo
AET
Aetna
$60.54B1.15$12.44 per share17.10$56.70 per share3.75
CVS Health Corporation stock logo
CVS
CVS Health
$372.81B0.27$9.15 per share8.57$60.18 per share1.30
Guardant Health, Inc. stock logo
GH
Guardant Health
$828.85M9.37N/AN/A($1.13) per share-55.14
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
$2.31B9.00$4.15 per share8.58$17.56 per share2.03
Tempus AI, Inc. stock logo
TEM
Tempus AI
$693.40M23.82N/AN/A$0.35 per share271.67
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aetna Inc. stock logo
AET
Aetna
$1.90B$9.8621.5717.151.825.99%20.78%6.22%N/A
CVS Health Corporation stock logo
CVS
CVS Health
$4.61B$3.5821.9011.580.861.17%10.51%3.15%10/29/2025 (Estimated)
Guardant Health, Inc. stock logo
GH
Guardant Health
-$436.37M-$3.35N/AN/AN/A-49.93%N/A-28.95%10/29/2025 (Estimated)
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
$858.98M$1.7320.547.321.9844.23%25.54%14.11%11/5/2025 (Estimated)
Tempus AI, Inc. stock logo
TEM
Tempus AI
-$705.81M-$1.19N/AN/AN/A-20.98%-122.86%-18.09%11/3/2025 (Estimated)

Latest AET, CVS, RPRX, TEM, and GH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2025Q3 2025
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
$1.11N/AN/AN/A$765.01 millionN/A
11/3/2025Q3 2025
Tempus AI, Inc. stock logo
TEM
Tempus AI
-$0.16N/AN/AN/A$328.89 millionN/A
10/29/2025Q3 2025
CVS Health Corporation stock logo
CVS
CVS Health
$1.36N/AN/AN/A$98.85 billionN/A
10/29/2025Q3 2025
Guardant Health, Inc. stock logo
GH
Guardant Health
-$0.48N/AN/AN/A$235.72 millionN/A
8/8/2025Q2 2025
Tempus AI, Inc. stock logo
TEM
Tempus AI
-$0.23-$0.22+$0.01-$0.25$296.84 million$314.64 million
8/6/2025Q2 2025
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
$1.10$1.14+$0.04$0.05$750.06 million$578.67 million
7/31/2025Q2 2025
CVS Health Corporation stock logo
CVS
CVS Health
$1.46$1.81+$0.35$0.80$94.87 billion$98.92 billion
7/30/2025Q2 2025
Guardant Health, Inc. stock logo
GH
Guardant Health
-$0.52-$0.44+$0.08-$0.80$211.19 million$232.09 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aetna Inc. stock logo
AET
Aetna
$2.000.94%N/A20.28%N/A
CVS Health Corporation stock logo
CVS
CVS Health
$2.663.39%N/A74.30%4 Years
Guardant Health, Inc. stock logo
GH
Guardant Health
N/AN/AN/AN/AN/A
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
$0.882.47%N/A50.87%5 Years
Tempus AI, Inc. stock logo
TEM
Tempus AI
N/AN/AN/AN/AN/A

Latest AET, CVS, RPRX, TEM, and GH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/17/2025
CVS Health Corporation stock logo
CVS
CVS Health
quarterly$0.66503.59%10/23/202510/23/202511/3/2025
7/18/2025
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
quarterly$0.222.48%8/15/20258/15/20259/10/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aetna Inc. stock logo
AET
Aetna
0.42
0.79
0.79
CVS Health Corporation stock logo
CVS
CVS Health
0.74
0.80
0.62
Guardant Health, Inc. stock logo
GH
Guardant Health
N/A
3.71
3.35
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
0.74
1.26
1.26
Tempus AI, Inc. stock logo
TEM
Tempus AI
2.58
1.54
1.43

Institutional Ownership

CompanyInstitutional Ownership
Aetna Inc. stock logo
AET
Aetna
82.34%
CVS Health Corporation stock logo
CVS
CVS Health
80.66%
Guardant Health, Inc. stock logo
GH
Guardant Health
92.60%
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
54.35%
Tempus AI, Inc. stock logo
TEM
Tempus AI
24.22%

Insider Ownership

CompanyInsider Ownership
Aetna Inc. stock logo
AET
Aetna
1.21%
CVS Health Corporation stock logo
CVS
CVS Health
1.22%
Guardant Health, Inc. stock logo
GH
Guardant Health
6.10%
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
18.90%
Tempus AI, Inc. stock logo
TEM
Tempus AI
26.27%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aetna Inc. stock logo
AET
Aetna
N/A327.40 millionN/AOptionable
CVS Health Corporation stock logo
CVS
CVS Health
300,0001.27 billion1.25 billionOptionable
Guardant Health, Inc. stock logo
GH
Guardant Health
2,021124.71 million117.10 millionNot Optionable
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
80583.17 million472.95 millionOptionable
Tempus AI, Inc. stock logo
TEM
Tempus AI
2,400173.73 million128.09 millionN/A

Recent News About These Companies

Progress Vs. Price: Evaluating Tempus AI's High Valuation Thesis
Tempus AI (NASDAQ:TEM) COO Sells $461,600.00 in Stock
Tempus AI, Inc. (TEM): A Bull Case Theory 
Tempus AI, Inc. (TEM): A Bull Case Theory

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Aetna stock logo

Aetna NYSE:AET

Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis. It also provides point-of-service, preferred provider organization, health maintenance organization, and indemnity benefit plans, as well as health savings accounts and consumer-directed health plans. In addition, this segment offers Medicare and Medicaid products and services, as well as other medical products, such as medical management and data analytics services, medical stop loss insurance, workers' compensation administrative services, and products that provide access to its provider networks in select geographies. The Group Insurance segment offers life insurance products, including group term life insurance, voluntary spouse and dependent term life insurance, group universal life insurance, and accidental death and dismemberment insurance; disability insurance products; and long-term care insurance products, which provide the benefits to cover the cost of care in private home settings, adult day care, assisted living, or nursing facilities. The Large Case Pensions segment manages various retirement products comprising pension and annuity products primarily for tax-qualified pension plans. The company provides its products and services to employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Aetna Inc. was founded in 1853 and is based in Hartford, Connecticut.

CVS Health stock logo

CVS Health NYSE:CVS

$78.42 +0.52 (+0.67%)
As of 03:07 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Guardant Health stock logo

Guardant Health NASDAQ:GH

$62.31 -1.91 (-2.98%)
As of 03:07 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Royalty Pharma stock logo

Royalty Pharma NASDAQ:RPRX

$35.57 -0.44 (-1.22%)
As of 03:06 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, immunology, respiratory, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

Tempus AI stock logo

Tempus AI NASDAQ:TEM

$95.08 -1.31 (-1.36%)
As of 03:07 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.